Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.548
-0.082 (-2.26%)
Feb 21, 2025, 4:00 PM EST - Market closed
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $2.61 million as of February 21, 2025. Its market cap has increased by 4.51% in one year.
Market Cap
2.61M
Enterprise Value
3.66M
1-Year Change
4.51%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.40M to $2.61M, a decrease of -93.20%. That is a compound annual growth rate of -24.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.60M | -16.13% |
| Dec 31, 2024 | 3.10M | 10.71% |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.63% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |